Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 15/20 | 0.57 |
| ▸ | CDK6 | Q00534 | 15/20 | 0.57 |
| ▸ | CDK4 | P11802 | 14/20 | 0.57 |
| ▸ | AXL | P30530 | 2/20 | 0.52 |
| ▸ | JAK2 | O60674 | 1/20 | 0.47 |
| ▸ | JAK1 | P23458 | 1/20 | 0.47 |
| ▸ | FLT3 | P36888 | 1/20 | 0.47 |
| ▸ | JAK3 | P52333 | 1/20 | 0.47 |
| ▸ | PIK3CD | O00329 | 5/20 | 0.47 |
| ▸ | CCNA2 | P20248 | 3/20 | 0.47 |
| ▸ | CDK2 | P24941 | 3/20 | 0.47 |
| ▸ | CCNK | O75909 | 2/20 | 0.47 |
| ▸ | CDK7 | P50613 | 2/20 | 0.47 |
| ▸ | CDK9 | P50750 | 2/20 | 0.47 |
| ▸ | CCNH | P51946 | 2/20 | 0.47 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.47 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.47 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.46 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21267740 | 0.90 | CDK4 (0.58) | CSF1RCDK6CDK4JAK2JAK1 | |
| SCHEMBL21267388 | 0.90 | CDK4 (0.57) | CSF1RCDK6CDK4PIK3CDCCNA2 | |
| SCHEMBL25085680 | 0.85 | CDK6 (0.66) | CSF1RCDK6CDK4PIK3CDCCNA2 | |
| SCHEMBL21267071 | 0.78 | CSF1R (0.74) | CSF1RCDK6CDK4PIK3CDCCNA2 | |
| SCHEMBL21267030 | 0.78 | CDK6 (0.76) | CSF1RCDK6CDK4PIK3CDCCNA2 | |
| SCHEMBL21267795 | 0.77 | CDK4 (0.76) | CSF1RCDK6CDK4PIK3CDCCNA2 | |
| SCHEMBL21267470 | 0.77 | CDK4 (0.74) | CSF1RCDK6CDK4PIK3CDCCNA2 | |
| SCHEMBL21267160 | 0.76 | CSF1R (0.76) | CSF1RCDK6CDK4PIK3CDCCNA2 | |
| SCHEMBL21267504 | 0.73 | CDK4 (0.74) | CSF1RCDK6CDK4PIK3CDCCNA2 | |
| SCHEMBL21267070 | 0.73 | CDK4 (0.74) | CSF1RCDK6CDK4PIK3CDCCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230062022-A1 | HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | NUVATION BIO INC (US) | 2023-03-02 | — | — | US | disclosed |
| US-11174252-B2 | Heterocyclic compounds as kinase inhibitors | NUVATION BIO INC. (US) | 2021-11-16 | — | — | US | disclosed |
| US-20190248774-A1 | HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | SAGARD HOLDINGS MANAGER LP, AS ADMINISTRATIVE AGENT (CA) | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11174252-B2 | Heterocyclic compounds as kinase inhibitors | CDK6, CDK4, CDK9 | CSF1R 3721/4885CDK6 1/4885CDK4 2/4885 |
| US-20190248774-A1 | HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | CDK4, CDK6, CDK8 | CSF1R 4272/4885CDK6 2/4885CDK4 1/4885 |
| US-20230062022-A1 | HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | CDK4, CDK6, CDK8 | CSF1R 4272/4885CDK6 2/4885CDK4 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.